Skip to main content
. 2015 Aug 26;75(16):1857–1867. doi: 10.1002/pros.23059

Figure 6.

Figure 6

I‐PSS adjusted* mean change from baseline to end of treatment (D90). In HESr group, response to I‐PSS at D90 was evaluated in patients who over expressed MIF protein at baseline (>3rd quartile) to those who did not over express this protein. * using Ancova model change=baseline+treatment. **>Q3 corresponds to the 25% of patients who expressed MIF at the highest level.